.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Argus Health
McKinsey
Fish and Richardson
US Department of Justice
Baxter
Harvard Business School
Cerilliant
Moodys
McKesson

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012945

« Back to Dashboard
NDA 012945 describes DIAMOX, which is a drug marketed by Teva Branded Pharm and Teva Womens and is included in three NDAs. It is available from two suppliers. Additional details are available on the DIAMOX profile page.

The generic ingredient in DIAMOX is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for NDA: 012945

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 012945

Ingredient-typeSulfonamides
Mechanism of ActionCarbonic Anhydrase Inhibitors

Suppliers and Packaging for NDA: 012945

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIAMOX
acetazolamide
 CAPSULE, EXTENDED RELEASE;ORAL 012945 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0513 0555-0513-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0513-02)
DIAMOX
acetazolamide
 CAPSULE, EXTENDED RELEASE;ORAL 012945 NDA Teva Women's Health, Inc. 51285-754 51285-754-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51285-754-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Fuji
Mallinckrodt
Teva
Queensland Health
Chubb
Medtronic
McKinsey
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot